Your gift is 100% tax deductible
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Take a shot at helping to end prostate cancer.
Your support helps more people get care, advances research, and fuels lifesaving treatment.
The amount must be greater than or equal to $5
Your gift is 100% tax deductible
Retinoblastoma is a rare cancer of the eye. Most retinoblastoma is diagnosed in young children. Retinoblastoma is a type of eye cancer that usually starts because of a change in a gene called RB1.
Changes in the RB1 genes are responsible for most cases of retinoblastoma. Normally, the RB1 genes help keep cells from growing too fast. Each cell normally has two RB1 genes. As long as a retinal cell has at least one RB1 gene that works as it should, it will not form retinoblastoma. However, when both RB1 genes are damaged, cells can grow out of control, resulting in cancer. However, the cause of damage to this gene is largely unknown.
The RB1 gene is a tumor suppressor gene. In rare cases, changes in the BCOR gene (a tumor suppressor gene) or amplification of MYCN (an oncogene) have been found in retinoblastoma cells. Learn more how these types of genes work on Oncogenes, Tumor Suppressor Genes, and DNA Repair Genes.
While changes in the RB1 gene account for most cases of retinoblastoma, those gene changes can be sporadic or heritable.
Sporadic gene changes are due to chance and start in a single cell. They are present in about 60% of children diagnosed with retinoblastoma. Retinoblastomas caused by a sporadic RB1 gene change:
Heritable gene changes affect cells all over the body. They are present in about 40% of children with retinoblastoma. Heritable gene changes can happen early in development, while the child is still in the womb, or children can inherit an RB1 gene change from a parent. Features of retinoblastoma caused by heritable RB1 gene changes include:
Children with heritable RB1 changes have a higher risk of some other types of cancer as they age. For more information, see Hereditary Retinoblastoma.
A risk factor is anything that affects the chance of having a disease such as cancer. Different cancers have different risk factors.
Unlike adult cancers, lifestyle-related risk factors such as body weight, physical activity, diet, and the use of tobacco and alcohol do not play a major role in pediatric cancers. In many cases, researchers do not know what causes the gene changes responsible for retinoblastoma. Other potential risk factors for retinoblastoma are still being studied.
Most children diagnosed with retinoblastoma are younger than 3 years old. Most heritable retinoblastomas are found during the first year of life, while nonheritable retinoblastomas tend to be diagnosed in 1- and 2-year-olds. Retinoblastomas are rare after age 6.
The risk of retinoblastoma is much higher in children of a parent with heritable retinoblastoma. Parents with heritable retinoblastoma have a 1 in 2 chance of passing the RB1 gene change to their children. In those children who inherit the abnormal gene, it is very likely (>90%) the child will develop retinoblastoma. Heritable retinoblastoma often results in retinoblastoma that is diagnosed at younger ages and can be multifocal (multiple tumors in one eye), bilateral (tumors in both eyes), or trilateral (retinoblastoma and a brain tumor in the pineal or parasellar region).
Only 1 in 4 children with heritable retinoblastoma have a family history of retinoblastoma. That’s why gene testing is important to identify children with the heritable form of the disease. For more information, see Hereditary Retinoblastoma.
Most of the time, there are no identified parental risk factors for retinoblastoma. Some small studies have identified that parents’ exposure to certain things might raise the risk of a child developing retinoblastoma. These include:
In adults, the risk for cancers can be reduced by avoiding certain risk factors, such as smoking or exposure to hazardous chemicals in the workplace. However, there are no known avoidable risk factors for retinoblastoma. If your child has retinoblastoma, it is important to know that you and your child did nothing to cause it.
In some cases, parents who had heritable retinoblastoma can pass on the RB1 gene change that increases cancer risk for their children. People who have had retinoblastoma might want to consider genetic counseling before having children to learn more about the risk of passing on this gene change and perhaps to explore ways to avoid this. For example, an option some people might consider would be to use in vitro fertilization (IVF) and implant only embryos that do not have the gene change.
If a preventive option is not used, children born to a parent with a history of retinoblastoma should be screened carefully starting shortly after birth, because early detection of this cancer greatly improves the chance for successful treatment. For more information on the management and early detection of retinoblastoma in these children, see Hereditary Retinoblastoma.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Bunin GR, Tseng M, Li Y, Meadows AT, Ganguly A. Parental diet and risk of retinoblastoma resulting from new germline RB1 mutation. Environ Mol Mutagen. 2012;53(6):451-461.
Heck JE, Omidakhsh N, Azary S, et al. A case-control study of sporadic retinoblastoma in relation to maternal health conditions and reproductive factors: a report from the Children's Oncology group. BMC Cancer. 2015;15:735.
Kamihara J, Bourdeaut F, Foulkes WD, et al. Retinoblastoma and Neuroblastoma Predisposition and Surveillance. Clin Cancer Res. 2017;23(13):e98-e106.
Kamihara J, Schienda J, McGee RB, et al. Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clin Cancer Res. 2025;31(9):1573-1579.
Leahey AM, Gombos DS, Chevez-Barrios P. Chapter 32: Retinoblastoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Pediatric Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2021.
National Cancer Institute. Retinoblastoma Treatment (PDQ®). 2025. Accessed at www.cancer.gov/types/retinoblastoma/hp/retinoblastoma-treatment-pdq on July 2, 2025.
Omidakhsh N, Bunin GR, Ganguly A, et al. Parental occupational exposures and the risk of childhood sporadic retinoblastoma: a report from the Children's Oncology Group. Occup Environ Med. 2018;75(3):205-211.
Omidakhsh N, Ganguly A, Bunin GR, von Ehrenstein OS, Ritz B, Heck JE. Residential Pesticide Exposures in Pregnancy and the Risk of Sporadic Retinoblastoma: A Report From the Children's Oncology Group. Am J Ophthalmol. 2017;176:166-173.
Last Revised: September 11, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.